AMD Acquires Brium to Boost AI Performance, Challenges Nvidia’s Dominance
On June 4, Advanced Micro Devices Inc.
Insider Monkey Blog
Barclays Lowers Victoria’s Secret & Co. (VSCO) Price Target to $22, Keeps Overweight Rating
On June 5, Barclays analyst Adrienne Yih slashed the firm's price target on Victoria's Secret & Co.
Evercore Raises Walmart (WMT) Price Target, Keeps Outperform Rating
On Wednesday, June 4, Evercore ISI analysts raised the price target on Walmart Inc. (NYSE:WMT) from $105 to $107 and kept an “Outperform” rating.
Amazon to Test Humanoid Robots for Last-Mile Delivery With Rivian Vans
On June 4, Amazon Inc. (NASDAQ:AMZN) announced plans to begin testing humanoid robots for package delivery.
BofA Lowers PT for Old Dominion (ODFL), Maintains Neutral Rating
Ken Hoexter from BofA made the update following Old Dominion’s mid-second quarter 2025 result.
BofA Reiterates Buy Rating on Asana (ASAN), Lowers PT to $21
On June 4, Bank of America Securities analyst Michael Funk reiterated a Buy rating for Asana, Inc. (NYSE:ASAN), reducing the price target to $21 from $23.
H.C. Wainwright Reiterates Buy Rating on Immix Biopharma (IMMX) Following Promising Interim Results from NXC-201 Trial
On June 4, analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Immix Biopharma, Inc. (NASDAQ:IMMX) with a price target of $7.00.
Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target
In a report released on June 4, Dennis Ding from Jefferies maintained a Buy rating on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) with a price target of $80.00.
Truist Financial Maintains Buy Rating on Sixth Street Specialty Lending (TSLX)
Sixth Street Specialty Lending Inc.
DBS Maintains Hold Rating on NIO Inc. (NIO) Stock
On June 5, DBS analyst Rachel Miu maintained a Hold rating on NIO Inc. (NYSE:NIO) and set a price target of HK$38.00.
H.C. Wainwright Initiates Coverage of Akebia Therapeutics (AKBA) With Buy Rating
Matthew Caufield, an analyst from H.C. Wainwright, initiated coverage of Akebia Therapeutics, Inc. (NASDAQ:AKBA) with a Buy rating and a $8 price target, on June 4.
TD Cowen Initiates Coverage of Target (TGT) With Hold Rating
The analysts noted that the company’s strong core business is supported by innovative and exclusive products.
BofA Maintains Hold Rating on PVH Corp. (PVH), Sets $86 PT
In a report released on June 4, BofA analyst Christopher Nardone maintained a Hold rating on PVH Corp. (NYSE:PVH) with a price target of $86.00.
Morgan Stanley Maintains Hold Rating on Snowflake (SNOW), Keeps $200 PT
Keith Weiss from Morgan Stanley maintained a Hold rating on Snowflake Inc. (NYSE:SNOW) on June 4, keeping the associated price target at $200.00.
Morgan Stanley Slashes Asana (ASAN) Price Target to $13, Keeps Underweight Rating
The rating update came after the company announced fiscal Q1 2026 results on June 3, with revenue reaching $187.3 million, reflecting a 9% year-over-year growth.
Wells Fargo Remains Bullish on Snowflake (SNOW), Keeps Buy Rating
The analyst based his rating on the company's growth potential and strategic positioning, particularly due to its focus on integrating AI into its product offerings.
Amazon (AMZN) Pledges $10 Billion to Expand AI Infrastructure in North Carolina
The investment is expected to create over 500 jobs for data center engineers, network specialists, and other technical roles.
Jim Cramer Put These 14 Stocks Under the Microscope
During Wednesday’s episode of Mad Money, host Jim Cramer weighed in on the dynamics between the United States and China, especially in relation to President Donald Trump's trade...
Three Megatrends. One Overlooked Stock. Massive Upside
There’s a once-in-a-generation convergence happening right now.
RTX Corporation (RTX), Northrop Grumman Corporation (NOC) Complete Rocket Motor Tests for Army’s NGSRI
On Thursday, RTX Corporation (NYSE:RTX)’s Raytheon business and Northrop Grumman Corporation (NYSE:NOC) announced the completion of four successful tests of flight-ready Highly...
Hedge Fund and Insider Trading News: Bill Ackman, Ken Griffin, Warren Buffett, Brevan Howard, Illinois Tool Works Inc (ITW), Block Inc (XYZ), and More
You may be concerned about the recent declines in AI stocks such as NVDA.
BofA Still Sees Trouble on the Road for Lyft (LYFT)
On June 4, Bank of America Securities analyst Mike McGovern reiterated a Sell rating on Lyft Inc. (NASDAQ:LYFT), with an unchanged price target of $12.
Rosenblatt Raises Lumentum (LITE) Price Target, Keeps Buy Rating
The increased price target reflects better gross margins in Lumentum Holdings Inc.’s (NASDAQ:LITE) 800G transceiver segment, driven by vertical integration and the launch of...
Toyota Industries’ (TYIDF) Privatization Plan Met with Scrutiny Over Valuation
On June 4, Bloomberg reported that the Toyota Group has announced a ¥4.7 trillion ($33 billion) plan to take Toyota Industries Corporation (OTC:TYIDF) private.
Loop Capital Raises Snowflake (SNOW) Price Target, Maintains Buy Rating
[caption id="attachment_1196210" align="aligncenter" width="1456"] A software engineer at work, surrounded by a wall of computer monitors connected to a 'Data Cloud' platform.[/...
Cantor Fitzgerald Lifts Etsy (ETSY) Price Target, Keeps Neutral Rating
On Wednesday, June 4, Cantor Fitzgerald analysts increased the price target for Etsy, Inc. (NASDAQ:ETSY) from $47 to $52 and kept a “Neutral” rating.
5 Signs You Are Trading With a Broker You Can Trust
When choosing an online broker, there are several key factors to consider before making a decision.
Was Jim Cramer Right About These 9 Stocks?
During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies depend on China, during a time when the U.S.
RBC Capital Maintains ‘Outperform’ Rating on Adobe (ADBE), Keeps $480 Price Target
On June 5, RBC Capital maintained its ‘Outperform’ rating on Adobe Inc. (NASDAQ:ADBE), leaving the price target unchanged at $480.
Jefferies Reiterates ‘Hold’ Rating on Fiserv (FI), Keeps PT
On June 5, analysts at Jefferies reiterated a ‘Hold’ rating on Fiserv, Inc. (NYSE:FI) and a $165 price target.
Jefferies Raises Carvana (CVNA) PT to $315, Maintains Hold Rating
On June 5, Jefferies analysts reiterated a ‘Hold’ rating on Carvana Co. (NYSE:CVNA) but hiked their price target to $315 from $280.
DA Davidson Reiterates Buy Rating on MongoDB (MDB), Keeps PT
On June 5, DA Davidson analysts reiterated a ‘Buy’ rating on MongoDB Inc. (NASDAQ:MDB) stock and stuck with the $275 price target.
Citi Maintains Sell Rating on Enphase (ENPH), Lowers Price Target to $43
On June 5, analysts at Citi reiterated a ‘Sell’ rating on Enphase Energy, Inc. (NASDAQ:ENPH) but cut their price target to $43 from $47.
Wells Fargo Turns More Bullish on Ferguson (FERG), Raises TP
On June 4, Wells Fargo analyst Sam Reid reiterated a Buy rating on Ferguson Enterprises Inc. (NYSE:FERG), while raising the price target from $190 to $230.
Bell Media Partners with Magna for Autonomous Vehicle Advertising in Toronto
On Thursday, BCE Inc.
Avadel Pharmaceuticals Receives Orphan Drug Designation for LUMRYZ in IH
On Thursday, Avadel Pharmaceuticals (NASDAQ:AVDL) announced that its drug LUMRYZ (sodium oxybate) for extended-release oral suspension has been granted Orphan Drug Designation...
Colliers Completes Acquisition of Triovest
On Thursday, Colliers International Group Inc. (NASDAQ:CIGI) announced the completion of its previously announced acquisition of Triovest Inc.
Ballard Power Systems Secures 1.5MW Fuel Cell Order for California Rail Decarbonization
On Thursday, Ballard Power Systems Inc.
Cellebrite DI to Acquire Corellium for $170M
The acquisition is valued at an enterprise value of $170 million in cash, with $20 million converted to equity at closing.
Estrella Immunopharma Expands STARLIGHT-1 Trial with New Texas Clinical Site
The trial is evaluating EB103, which is a CD19-redirected ARTEMIS® T-cell therapy, in adult patients (aged 18 and older) with relapsed or refractory B-cell non-Hodgkin’s lymphoma...
BYD To Triple Its South African Dealerships By 2026
On Thursday, BYD Company Limited (OTC:BYDDF) announced plans to nearly triple its dealership network in South Africa by 2026.
Blink Charging, WirelessCar, and ChargeHub Launch Seamless Charging EV Pilot in North America
On June 3, WirelessCar announced a collaboration with Blink Charging Co. (NASDAQ:BLNK) and ChargeHub.
Iridium Launches Chat App, Unlimited Plan for Enhanced Global Off-Grid Messaging
On June 3, Iridium Communications Inc. (NASDAQ:IRDM) announced the launch of its new Iridium Chat app.
Fidelity National Tapped by ATLAS SP Partners to Support Commercial Loan Servicing
On June 3, Fidelity National Information Services Inc. (NYSE:FIS) announced that ATLAS SP Partners selected its Commercial Loan Servicing solution.
Snapchat Unveils Standalone App for Making GenAI AR effects
On June 4, Snap Inc. (NYSE:SNAP) officially launched new and more accessible versions of its Lens Studio: a standalone iOS app and a web tool.
Amneal Pharmaceuticals Initiates Nationwide Recall of Contaminated Sulfamethoxazole/Trimethoprim Tablets
On June 1, Amneal Pharmaceuticals Inc. (NASDAQ:AMRX) initiated a nationwide recall of 3 specific lots of its Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg.
IBM and Inclusive Brains Partner to Advance Mind-Controlled Computing with AI, Quantum Tech
On June 3, International Business Machines Corporation (NYSE:IBM) and French startup Inclusive Brains announced a joint study agreement to advance mind-controlled computing.
Citi Raises Barclays (BCS) PT to 360 GBp on Strong Q1 2025 Performance
In Q1 2025, Barclays reported a Return on Tangible Equity (RoTE) of 14% for. Total income for the quarter was GBP7.7 billion, with a cost-income ratio of 57%.
Barclays Boosts Argenx (ARGX) PT to EUR 680 After Strong Q1 2025 Performance
On June 4, Barclays raised its price target for Argenx (NASDAQ:ARGX) from EUR 650 to EUR 680, while keeping an Overweight rating on the company's shares.
Wells Fargo Raises Celsius (CELH) PT to $45, Maintains Overweight Rating
On June 4, Wells Fargo increased its price target for Celsius Holdings Inc. (NASDAQ:CELH) to $45 from $44, while maintaining an Overweight rating.
Hedge Fund Resource Center
